Wednesday, March 3, 2021
Home News Reports Bharat Biotech's potential COVID-19 vaccine 'Covaxin' enters clinical trials after DGCI approval

Bharat Biotech’s potential COVID-19 vaccine ‘Covaxin’ enters clinical trials after DGCI approval

Bharat Biotech has developed the potential vaccine in collaboration with the National Institute of Virology, and Indian Council of Medical Research (ICMR).

Bharat Biotech, one of India’s leading Bio-Technology companies, has got approval for human trials of their potential Covid-19 vaccine Covaxin from Drug Controller General of India on 29th June. DGCI, the drug regulator body, has permitted the company to conduct phase I and phase II clinical trials for the first indigenous Covid-19 vaccine that are expected to begin in July. Bharat Biotech has developed the potential vaccine in collaboration with the National Institute of Virology, and Indian Council of Medical Research (ICMR).

Promising pre-clinical studies led to trial approval

The company presented the results of pre-clinical studies of the potential vaccine that ensure safety and immunity response. The pre-clinical trials of the potential Covid-19 vaccine took two months to complete after getting approval from the regulatory body. Krishna Ella, Chairman and MD of Bharat Biotech, said, “The collaboration with NIV was instrumental in developing this vaccine. The proactive support and guidance from CDSCO have enabled approvals to this project.” The vaccine is being developed in a high containment facility in Hyderabad.

Ella added that their ongoing research and expertise in forecasting epidemics had enabled them to successfully manufacture a vaccine for the H1N1 pandemic. “Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India’s strength in handling the future pandemics.”

Race to develop vaccine for Covid-19

There are around 86 teams working across the globe to develop vaccines for Covid-19. Some of them have already entered clinical trials. According to the World Health Organization, 13 vaccines are undergoing clinical trials. 129 vaccines are currently in the pre-clinical evaluation phase. In India, Zydus Cadila, Serum Institute of India and other Indian pharma companies are developing a vaccine for the infection.

Rising Covid-19 cases in India

As per the Ministry of Health, out of 5,49,946 cases in India, 3,34,821 patients have been cured while 16,893 have lost their lives due to complications related to Covid-19. 2,15,125 cases are still active in the country, with Maharashtra having maximum cases, followed by Tamil Nadu and Delhi.

  Support Us  

Whether NDTV or 'The Wire', they never have to worry about funds. In name of saving democracy, they get money from various sources. We need your support to fight them. Please contribute whatever you can afford

OpIndia Staff
Staff reporter at OpIndia

Related Articles

Trending now

Ahmedabad netizens trend #WeWantKarnavati to get city name changed, this is why

Ahmedabad residents said that the city was not 'established' by Mughal emperor Ahmed Shah but it was developed by King Karna Dev and hence it should be named after him.

Ex Maha CM and Congress leader spreads misinformation about COVID vaccination. Here are the facts about pricing

Congress leader Prithviraj Chavan spreads misinformation about Covid-19 vaccine pricing and allocation.

Take a shot every time Rahul Gandhi says ‘strategy’ and get drunk before noon: Rahul Gandhi’s bizarre monologue goes viral

Rahul Gandhi thinks China has a 'vision' of 'modern Silk Road' with a 'nervous system' - we have no idea what he means by that.

West Bengal: Minor girl missing for 22 days, family accuses TMC leader and 5 others of abduction

Faced with police inaction in recovering the victim and the barrage of incoming threats, the family members sat on a hunger strike on Monday night in the Fuara More area of Malda.

‘Standing up for the national anthem is enforced nationalism’: Here’s how The Wire is fanning separatism in J and K

In essence, The Wire, in its article, has toed the separatists and terrorists' line in blaming the university for "enforcing" nationalism on students by simply asking them to comply with the university protocols, which include standing up for the national anthem, among other activities.

Central government gives nod to ‘Maryada Purushottam Sriram Airport’ in Ayodhya, sanctions Rs 250 crores: Details

The UP government has set the December 2021 deadline for completion of the Maryada Purushottam Sriram Airport in Ayodhya

Recently Popular

‘Inserted her hand claiming she was planting a tree’: LGBT activist Divya Dureja accused of sexual assault under pretext of shamanic ritual

A popular LGBT activist Divya Dureja has been accused of sexual assault by Elodie Gendron under pretext of a Shamanic ritual.

Sourav Ganguly may attend PM Modi’s Brigade Ground rally in Kolkata on 7th March: Local media

Sourav Ganguly may attend PM Modi's rally at Brigade Ground in Kolkata on March 7, according to reports in local media.

Aamir Khan shelves Mahabharat amidst controversies because ‘now is not the right time’: Reports

Aamir Khan has shelved his 'Mahabharat' project amidst controversies because the 'timing' is not right, reports say.

A woman molested, a father murdered, a Samajwadi Party leader accused: Here is all you need to know about the Hathras case

"Aatankwadi hain woh", Hathras victim Pooja exclaimed, expressing her angst against the SP leader for killing her father

The Hindu ‘journalist’ Suhasini Haidar puts out misinformation about ISRO satellite launch: Read details

Suhasini Haidar, National Editor of 'The Hindu', put out false information on social media in attempt to mislead the public.

Gujarat: Ahmedabad woman Ayesha commits suicide by jumping into Sabarmati River, last video message goes viral

A video has gone viral on social media where Ayesha, a young woman, can be heard announcing her decision to commit suicide.
- Advertisement -


Connect with us